Cemax display stations win FDA nod
PACS developer Cemax is puttingthe regulatory pieces together for its line of image managementand archiving products. Cemax received Food and Drug Administration510(k) marketing clearance last month for its ClinicalView andDiagnosticView workstations,
PACS developer Cemax is puttingthe regulatory pieces together for its line of image managementand archiving products. Cemax received Food and Drug Administration510(k) marketing clearance last month for its ClinicalView andDiagnosticView workstations, two of the products in the Fremont,CA, vendor's Perfect Vision series of display technology.
ClinicalView is a Sun-based display station designed for nurses,physicians and technologists at hospital locations outside theradiology department, such as emergency and critical care units.The workstation has a resolution of 1280 x 1600 on a 24-inch portraitmonitor.
DiagnosticView, also a Sun-based system, is a review stationwith 2000 x 2000-pixel resolution, 21-inch portrait monitors foruse by radiologists. Both workstations support Fuji and Du Pontcomputed radiography devices and interfaces with Lumisys and DuPont digitizers.
The display stations archive to 8-mm digital tape and aresupported by the company's ImageServer distributed image managementand archiving architecture. Cemax received FDA clearance for itsImageServer software last year (SCAN 12/29/93).
Cemax signed a joint sales and marketing agreement with 3Min February for the Perfect Vision products. 3M unveiled the Cemaxline as the 3M Image Management System at last month's AmericanInstitute of Ultrasound in Medicine meeting.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
